Using co-immunofluorescence staining of Alzheimer’s disease brain tissues, we confirmed pathologic downregulation of ERBB4 and transcription factor NFIA in reactive astrocytes. The gene discussed is NFIA; the disease is early-onset autosomal dominant Alzheimer disease.